Study Finds High Number of European Cancer Drug Trials at Risk for Bias

Half of the cancer drug trials that led to approvals by the European Medicines Agency may have been associated with a high risk for bias.

Source: CancerNetwork - October 4, 2019 Category: Cancer & Oncology Authors: Seth Augenstein Source Type: news